Skip to content
Research Article Open access CC BY 4.0

Mineral and Bone Disorders in Pre-dialysis Chronic Kidney Disease

Deepak Kumar Chitralli, Brian Mark Churchill

International Journal of Advances in Nephrology Research · pp. 11–20 · Published 20 Jul 2020

Abstract

Chronic kidney disease (CKD) affects 9.1% of the world population (estimated in 2017). The estimates indicate that globally 1.2 million people died of CKD in 2017. As kidney function declines, there is a progressive deterioration in mineral homeostasis. There are changes in circulating levels of hormones as well including parathyroid hormone (PTH), vitamin D, fibroblast growth factor-23 (FGF-23), and growth hormone. Studies have also found association between MBD and fractures, cardiovascular disease (CVD) and mortality. It is well established that abnormalities in mineral metabolism are apparent early in the course of chronic kidney disease (CKD). This study was undertaken to assess and compare the biochemical markers of bone mineral disorders in diabetics with early CKD and non-diabetics with early CKD.

Mineral and bone disorders chronic kidney disease hypocalcemia in CKD hyperphosphatemia in CKD alkaline phosphatase in CKD parathyroid hormone in CKD vitamin D in CKD.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.